Enveda Therapeutics India Private Limited

Enveda Therapeutics India Private Limited - travel and hospitality in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U73100AP2019FTC112638 Incorporated 08 August 2019 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Foreign Private Limited Company travel and hospitality
Revenue · FY 2023
₹32.77 Cr
▲ 117% YoY
Net profit · FY 2023
₹5.69 Cr
Net margin 17.3%
EBITDA · FY 2023
₹10.91 Cr
EBITDA margin 33.3%
Authorised capital
₹50.5 Lakh
Registered with MCA
Paid-up capital
₹49.63 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
172
Provident fund records
Directors on board
2
As per MCA filings

About Enveda Therapeutics India Private Limited

Data last updated:

Enveda Therapeutics India Private Limited is a foreign private limited company based in Visakhapatnam, Andhra Pradesh, India, a subsidiary of Enveda Therapeutics Inc. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 08 August 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U73100AP2019FTC112638. Its GSTIN is 37AAFCE5951N1Z3 (Andhra Pradesh). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹50.5 Lakh and a paid-up capital of ₹49.63 Lakh. It is led by directors Viswa Teja Saraschandra Srinivasa Colluru and Nookayyasatya Prakasa Krishna Rao Colluru.

Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 502 Sri Prayaga Residency Mythreyi Nagar Pandurangapuram, Visakhapatnam, Andhra Pradesh, India – 530003.

As per the financials filed for FY 2023, the company reported a revenue of ₹32.77 Cr, a growth of 117% compared to the previous year. For the same year it recorded a net profit of ₹5.69 Cr (net margin 17.3%) and EBITDA of ₹10.91 Cr (EBITDA margin 33.3%). Revenue has grown at a compounded annual rate (CAGR) of 222% over three years.

The company has about 172 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Enveda. The company has 2 deals on record (2 rights issues); the latest was in September 2020.

For more details, the company can be reached via its website envedabio.com.

Company details

CIN U73100AP2019FTC112638
Registration Number 112638
Incorporation Date 08 August 2019
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Parent Company Enveda Therapeutics Inc

Contact details

Enveda Therapeutics India Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is envedabio.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    502 Sri Prayaga Residency Mythreyi Nagar Pandurangapuram, Visakhapatnam, Andhra Pradesh, India – 530003
  • Industry
    Travel and Hospitality, Consumer Professional Services

To see the full contact details of Enveda Therapeutics India Private Limited, buy the company report.

Comprehensive company report
Enveda Therapeutics India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Enveda Therapeutics India operates one associated brand: Enveda. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of AI-based platform to decipher the chemistry of nature and develop new medicinesenveda.com

Financials of Enveda Therapeutics India Private Limited

FY 2024 filings available

Enveda Therapeutics India Private Limited reported revenue of ₹32.77 Cr (up 117% YoY) for FY 2023.

Revenue · FY 2023
₹32.77 Cr ▲ 117%
Net profit · FY 2023
₹5.69 Cr margin 17.3%
EBITDA · FY 2023
₹10.91 Cr margin 33.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 117%
3 years · compounded
▲ 222%
EBITDA CAGR growth
1 year
▲ 143%
3 years · compounded
▲ 276%

Revenue has grown at a compounded annual rate (CAGR) of 222% over three years, including 117% growth in the latest year. EBITDA rose 143% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations₹32.77 Cr
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.91 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.69 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin33.3%
Net Profit Margin17.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Enveda Therapeutics India Private Limited, buy the company report.

Board of directors of Enveda Therapeutics India Private Limited

Enveda Therapeutics India has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Viswa Teja Saraschandra Srinivasa ColluruDirector08 Aug 20197 Years 3 MonthsCurrent
Nookayyasatya Prakasa Krishna Rao ColluruDirector08 Aug 20197 Years 3 MonthsCurrent

Auditor

Enveda Therapeutics India Private Limited is audited by MISTRY & SHAH LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MISTRY & SHAH LLPFY 2023W100683

Shareholding

The shareholding of Enveda Therapeutics India Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Enveda Therapeutics India Private Limited, buy the company report.

Deals & funding

Enveda Therapeutics India Private Limited has 2 deals on record (2 rights issues); the latest was in September 2020.

Total deals
2
Rights issues
2

Deals on record (2 of 2)

WhenDealAmountParties
Sep 2020Rights issue₹73.9 LakhInvestors: Enveda Therapeutics Inc.
Oct 2019Rights issue₹24 LakhInvestors: Enveda Therapeutics Inc.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Enveda Therapeutics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Enveda Therapeutics India Private Limited has a workforce of 172 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
172
Active EPFO establishments
1
Employee growth
26.5%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27172
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Enveda Therapeutics India Private Limited, buy the company report.

GST

Enveda Therapeutics India has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
37AAFCE5951N1Z3Andhra PradeshActive16 Sep 2019
36AAFCE5951N1Z5TelanganaActive13 Jul 2022

To see the full GST registrations and return filing status of Enveda Therapeutics India Private Limited, buy the company report.

Recent activity

Enveda Therapeutics India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Nookayyasatya Prakasa Krishna Rao Colluru was appointed as Director on 08 Aug 2019.

AGM
Enveda Therapeutics India Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Filing
Enveda Therapeutics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Appointed
Appointed
Incorporation
08 Aug 2019
Enveda Therapeutics India Private Limited was registered on 08 Aug 2019 with Roc Vijayawada & aged 7 years 3 months as per MCA records.

Frequently asked questions

Enveda Therapeutics India is an active foreign private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 08 August 2019 (7+ years old) and is registered under CIN U73100AP2019FTC112638.

Enveda Therapeutics India has 2 current directors:

The latest financial statements of Enveda Therapeutics India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Enveda Therapeutics India is 37AAFCE5951N1Z3, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAFCE5951N1Z5 (Telangana).

The CIN (Corporate Identification Number) of Enveda Therapeutics India is U73100AP2019FTC112638. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Enveda Therapeutics India was incorporated on 08 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Vijayawada.

Enveda Therapeutics India has 2 deals on record (2 rights issues); the latest was in September 2020.

Nookayyasatya Prakasa Krishna Rao Colluru was appointed as Director on 08 Aug 2019. Viswa Teja Saraschandra Srinivasa Colluru was appointed as Director on 08 Aug 2019.

Enveda Therapeutics India can be reached through the website envedabio.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.

The registered office of Enveda Therapeutics India is at 502 Sri Prayaga Residency Mythreyi Nagar Pandurangapuram, Visakhapatnam, Andhra Pradesh, India – 530003.